Brief: Lavipharm To Acquire Durogesic Pain Patch Rights From Janssen For $12.0 Million
April 9 (Reuters) - Lavipharm SA LPHr.AT: TO ACQUIRE DUROGESIC PAIN PATCH RIGHTS IN 24 COUNTRIES FROM JANSSEN UPFRONT PAYMENT FOR DUROGESIC ACQUISITION $12.0 MILLION TRANSACTION EXPECTED TO BOOST ANNUAL SALES BY MORE THAN 60% EXPORT ACTIVITY EXPECTED TO GROW BY MORE THAN 150% Further company coverage: [LPHr.AT] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 587785269;))
Recent news on Lavipharm SA
See all newsBrief: Lavipharm Q1 Earnings Before Tax From Continuing Operations €1.41 Million, Up 28.6% YoY
Brief: Lavipharm To Acquire Durogesic Pain Patch Rights From Janssen For $12.0 Million
Brief: Lavipharm SA FY 2025 Earnings After Tax EUR 6.0 Million Versus EUR 9.0 Million Year Ago
Brief: Lavipharm 9-Month Net Profit Down To EUR 3.5 Million
Brief: Lavipharm H1 Adjusted EBITDA At EUR 7.7 Million, Up 29.4% YoY